Trial NCT05967286

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2023-05623
Secondary IDs: EAY191-A2 NCI-2023-05623 U10CA180821

Last trial update was posted on 2024-03-20

MeSH Interventions

Olaparib Phosphoinositide-3 Kinase Inhibitors Poly(ADP-ribose) Polymerase Inhibitors

MeSH Conditions

Breast Neoplasms Carcinoma

Other Conditions

Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Metastatic HER2-Negative Breast Carcinoma Unresectable HER2-Negative Breast Carcinoma

Stopping Reasons

Other - Protocol moved to Withdrawn

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID